<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/1594AF38-7652-4453-83A4-113012910DD3"><gtr:id>1594AF38-7652-4453-83A4-113012910DD3</gtr:id><gtr:name>National Institute of Health</gtr:name><gtr:address><gtr:line1>National Institute of Health</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:department>College of Medical, Veterinary &amp;Life Sci</gtr:department><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1594AF38-7652-4453-83A4-113012910DD3"><gtr:id>1594AF38-7652-4453-83A4-113012910DD3</gtr:id><gtr:name>National Institute of Health</gtr:name><gtr:address><gtr:line1>National Institute of Health</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/85532D8A-C87C-4AA2-B554-D5C1538F1E44"><gtr:id>85532D8A-C87C-4AA2-B554-D5C1538F1E44</gtr:id><gtr:name>NHS Ayrshire &amp; Arran</gtr:name><gtr:address><gtr:line1>Dalmellington Road</gtr:line1><gtr:postCode>KA6 6DX</gtr:postCode><gtr:region>Scotland</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/D6507921-C2F8-4132-B692-562D7341E62C"><gtr:id>D6507921-C2F8-4132-B692-562D7341E62C</gtr:id><gtr:firstName>Ananda</gtr:firstName><gtr:otherNames>Shanti</gtr:otherNames><gtr:surname>Mirchandani</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0902003"><gtr:id>AE75888A-3506-4DF8-94B5-B70402043340</gtr:id><gtr:title>The role of nitric oxide-induced regulatory T cells in inflammation</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0902003</gtr:grantReference><gtr:abstractText>Numerous diseases have been found to be perpetuated by the uncontrolled actions of our own immune system. A group of regulatory immune cells have been recently discovered, which are able to modulate the immune system to avoid this. Unfortunately these cells are not able to suppress all inflammatory mechanisms leaving a dangerous gap in this balance.
A new group of regulatory cells, called NO-Tregs, have been described at the sponsoring laboratory and these cells appear to bridge the fissure left by conventional regulatory cells. NO-Tregs are capable of controlling the inflammatory response within cells detecting bacterial products, which if activated inappropriately, can lead to tissue damage. NO-Tregs are also able of suppressing a subgroup of cells whose enhanced presence has been implicated in numerous illnesses such as multiple sclerosis and asthma.
This project aims to investigate NO-Tregs further to understand the mechanisms by which these regulatory functions are achieved using both cell-based experiments as well as models of airway inflammation. Greater understanding of these mechanisms may prove vital in the future creation of targeted therapies aimed at redressing the careful balance in our immune system required in health.</gtr:abstractText><gtr:technicalSummary>There is increasing evidence supporting the vital role of regulatory T cells (Tregs) in immune mediated disease. The sponsor laboratory has recently described a new subset of Foxp3 negative
Tregs (NO-Tregs) induced by nitric oxide (NO). Our pilot data show that NO-Tregs suppress the differentiation and proliferation of Th17 cells which normally escape the suppression of conventional Tregs. Th17 is a novel subset of effector T cells which mediate a range of autoimmune diseases including rheumatoid arthritis and asthma. Our pilot data also show that NO-Tregs can suppress the function of the NALP3 inflammasome, responsible for the production of IL-1? and IL-18, key pro-inflammatory cytokines implicated in numerous disease states. The present project will test the hypothesis that NO-Tregs regulate both the adaptive and the innate immune system by suppressing Th17 cell differentiation/proliferation and the inflammasome, respectively. I will determine the potential role of NO-Tregs in vivo using an ovalbumin-induced airway inflammation model. In parallel, I will perform an in depth investigation of the molecular mechanisms by which this suppression is achieved using this in vivo and relevant ex vivo systems. This project will therefore advance understanding of fundamental immunology mechanisms with considerable potential for clinical applications in numerous autoimmune conditions. The project will provide me with advanced training in cellular, molecular and in vivo immunology in inflammation, dovetailed with my clinical training in respiratory medicine.</gtr:technicalSummary><gtr:fund><gtr:end>2012-07-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2010-08-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>221606</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute of Health</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:department>Department of Hematology, Oncology and Molecular Medicine</gtr:department><gtr:description>Novel allergic asthma model demonstrates ST2-dependent dendritic cell targeting by cypress pollen.</gtr:description><gtr:id>CFD42851-5FA3-4DA3-9D8F-172253D662E4</gtr:id><gtr:impact>PMID: 23608732</gtr:impact><gtr:outcomeId>58c2c73e43e2d3.35572886-1</gtr:outcomeId><gtr:partnerContribution>They performed all the other experiments described in the paper</gtr:partnerContribution><gtr:piContribution>We performed key in vivo experiments on ST2 knockout mice to show the role of dendritic cells in pollen-induced allergic disease which culminated in a publication.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>2000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>Annual Inflammatory Airway Diseases and Clinical Allergy Grant (for best abstract selected by 5 Members Association of European Respiratory Society)</gtr:description><gtr:end>2011-09-02</gtr:end><gtr:fundingOrg>European Respiratory Society (ERS)</gtr:fundingOrg><gtr:id>C5D72DF9-968D-4A2B-88E0-0B2BEB412D4F</gtr:id><gtr:outcomeId>pgodAaVJraN0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>ATS International Trainee Travel Award 2012</gtr:description><gtr:end>2012-06-02</gtr:end><gtr:fundingOrg>American Thoracic Society (ATS)</gtr:fundingOrg><gtr:id>AD97B3DC-1D03-4B38-8E89-4016B21B54AD</gtr:id><gtr:outcomeId>HNTssZeLDxv</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2012-05-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>49C57524-DC40-4E47-9FAD-C50559A32395</gtr:id><gtr:title>Type 2 innate lymphoid cells drive CD4+ Th2 cell responses.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/76a9c296c0e07da4d0fb0e98d30823d5"><gtr:id>76a9c296c0e07da4d0fb0e98d30823d5</gtr:id><gtr:otherNames>Mirchandani AS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>5406dbb4ad3399.32278575</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A41B4AA8-CE1D-4151-9DD2-8D2B68BB0F08</gtr:id><gtr:title>Innate lymphoid cells in type 2 immune responses.</gtr:title><gtr:parentPublicationTitle>Archivum immunologiae et therapiae experimentalis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/76a9c296c0e07da4d0fb0e98d30823d5"><gtr:id>76a9c296c0e07da4d0fb0e98d30823d5</gtr:id><gtr:otherNames>Mirchandani AS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0004-069X</gtr:issn><gtr:outcomeId>56cc6761083e27.73806450</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2D5D2788-B22C-434A-BB26-4D091DBB797A</gtr:id><gtr:title>IL-33 induces innate lymphoid cell-mediated airway inflammation by activating mammalian target of rapamycin.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/181788d1197fdc4cae30985077b49b51"><gtr:id>181788d1197fdc4cae30985077b49b51</gtr:id><gtr:otherNames>Salmond RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>pm_13117_27_22738676</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ED0CF817-BD9A-4ACE-AFB3-ED89429ABBA6</gtr:id><gtr:title>Interleukin-33 and the function of innate lymphoid cells.</gtr:title><gtr:parentPublicationTitle>Trends in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/76a9c296c0e07da4d0fb0e98d30823d5"><gtr:id>76a9c296c0e07da4d0fb0e98d30823d5</gtr:id><gtr:otherNames>Mirchandani AS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1471-4906</gtr:issn><gtr:outcomeId>pm_13117_27_22609147</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>14432B69-0903-4BF2-AAE2-C795B17C1A3A</gtr:id><gtr:title>Novel allergic asthma model demonstrates ST2-dependent dendritic cell targeting by cypress pollen.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2bf4678bffdcb0cafd313bbf3b4880bb"><gtr:id>2bf4678bffdcb0cafd313bbf3b4880bb</gtr:id><gtr:otherNames>Gabriele L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>pm_13117_27_23608732</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B2F72538-02E5-419B-A3F2-4F52205D7A82</gtr:id><gtr:title>Regulation of type 17 helper T-cell function by nitric oxide during inflammation.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/27d6c70628e2e918f4cbee0dcadac415"><gtr:id>27d6c70628e2e918f4cbee0dcadac415</gtr:id><gtr:otherNames>Niedbala W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>FesRV8M7Hzs</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0902003</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>